Aminophylline. Afonilum . Aminodur . Aminophyllin . Aminophylline DF . Cardophyllin . Carine . Clonofilin . Corophyllin . Diaphyllin . Drafilyn . Duraphyllin . Eufilina . Eufilina Venosa . Euphyllin . Euphyllin Retard . Euphylline . Godafilin . Mini-Lix . Mundiphyllin . Mundiphyllin Retard . Novophyllin . Phyllocontin . Phyllotemp . Somophyllin . Tari-Dog . Theophyllamin Jenapharm . Theophyllamine . Theophyllin EDA-ratiopharm . Theophylline Ethylenediamine . Truphylline . Ethylenediamine, Theophylline . Theophyllin EDA ratiopharm . Theophyllin EDAratiopharm . A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications. . 1.00
Dyphylline. Dilin . Diphylline . Dylix . Lufyllin . Neothylline . Dihydroxypropyltheophylline . Diprophylline . A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. . 0.45
Mentally Disabled Persons. Mentally Retarded . Disabled, Mentally . Mentally Disabled Person . Person, Mentally Disabled . Persons, Mentally Disabled . Mentally Disabled . Mentally Handicapped . Persons diagnosed as having significantly lower than average intelligence and considerable problems in adapting to everyday life or lacking independence in regard to activities of daily living. . 0.41
Diethylpropion. 2-Diethylaminopropiophenone . Amfepramone . Anorex . Delgamer . Diethylpropion Hydrochloride . Dietil-retard . Ifa Norex . Lipomin . Maruate . Modératan . Neobes . Nobesine . Phepranon . Propion . Préfamone . Regenon . Regibon . Tenuate . Tepanil . Dietil retard . Dietilretard . Hydrochloride, Diethylpropion . Norex, Ifa . Amfepramon . A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290) . 0.36